Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05942040 · ClinicalTrials.gov registry record · NA
Translating Data Science to Palliative Care
A NA study of Alzheimer's Disease and Related Dementias, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- NA
- Development phase
- 301
- Enrollment target
- 1
- Study location
NCT05942040: Completed NA study of Alzheimer's Disease and Related Dementias, sponsored by Rutgers, The State University of New Jersey.
NCT05942040 is a NA study of Alzheimer's Disease and Related Dementias that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 301 participants, below the 1,579-participant average among 5 other Alzheimer's Disease and Related Dementias trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05942040, a NA study of Alzheimer's Disease and Related Dementias, has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- NA
- Development phase
- 301 participants
- Enrollment target
- 1
- Study location
Study Summary
This research study is intended to 1) better understand seriously ill adults' and their family care partners' (FCP), particularly for persons living with dementia (PLwD), barriers to accepting community-based palliative care (CBPC); 2) develop an intervention to address barriers; and 3) pilot test whether the intervention has an impact on CBPC uptake. The intervention will consist of 1) a set of informational material describing the benefits of CBPC for the CBPC team to use when presenting CBPC to members of a Medicare Advantage plan and their FCP; and 2) processes for tailoring information delivery so that eligible members and their FCP receive information about CBPC that reflects their individualized risk as identified by the Medicare Advantage program's validated 12-month mortality risk algorithm. The clinical trial portion of the study refers to the pilot test (Aim 3 as described below).
Primary Outcome
The investigators will assess refusal rate using the MA plan's electronic health records. Refusal rate will be calculated as # of eligible individuals refusing palliative care / total # of individuals eligible for palliative care
Conditions Studied
Interventions
- OTHER Tailored Palliative Care Information
Study Locations (1)
New York
- VNS Health - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 301 participants |
| Start Date | 2024-02-15 |
| Est. Completion | 2024-09-30 |
| Phase | NA |
What the finished NCT05942040 record still lists
NCT05942040 is an interventional study that assigns participants to a tested intervention. The registered 301 participants enrollment target is mid-sized for trials with a published cap, below the 1,579-participant average among 5 other Alzheimer's Disease and Related Dementias trials with a reported enrollment target (81% lower).
The record links to 1 condition, with Alzheimer's Disease and Related Dementias appearing as the primary indexed condition, and to 1 intervention - of which Tailored Palliative Care Information is the first listed.
NCT05942040 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05942040 about?
NCT05942040 is a clinical study titled "Translating Data Science to Palliative Care". This research study is intended to 1) better understand seriously ill adults' and their family care partners' (FCP), particularly for persons living with dementia (PLwD), barriers to accepting community-based palliative care (CBPC); 2) develop an intervention to address barriers; and 3) pilot test w...
What is the current status of trial NCT05942040?
This trial is currently completed. It is a NA study. The enrollment target is 301 participants. The study started on 2024-02-15. Estimated completion is 2024-09-30.
What conditions does trial NCT05942040 study?
This clinical trial studies the following conditions: Alzheimer's Disease and Related Dementias.
What interventions are being tested in trial NCT05942040?
The interventions under investigation include: Tailored Palliative Care Information (OTHER).
Who is sponsoring clinical trial NCT05942040?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05942040 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alzheimer's Disease and Related Dementias
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Intervention to Collect and Utilize Sexual Orientation and Gender Identity (SOGI) Information in Hospice
RECRUITING · NA
-
Reducing Behavioral and Psychological Symptoms of Dementia: Hospital Caregivers (Aim 2)
COMPLETED · NA
-
Smart Lighting for Nursing Home Residents With Dementia
COMPLETED · NA
-
OPTIMAL in NH Residents With Dementia
COMPLETED · NA
-
Preventing Alzheimer's With Cognitive Training
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05005975 · 301 participants · Phase 3
Extension Study to Evaluate Safety and Tolerability of Oral Dersimelagon (MT-7117) in Subjects With Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP)
- NCT05722561 · 302 participants · Phase 2
E-Cigarettes for Harm Reduction in Smokers With Opioid Use Disorder
- NCT06015737 · 302 participants · Phase 3
A Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus
- NCT07176273 · 302 participants · NA
Adaptive Decision-making And Personalized Treatment for PTSD (ADAPT-PTSD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI